NCT04334863 WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain Tumors Status COMPLETED Phase PHASE1
NCT04334330 Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China Status UNKNOWN Phase PHASE2
NCT04291092 Camrelizumab Combined With Local Treatment in NSCLC Patients With BM Status UNKNOWN Phase PHASE2
NCT04246879 MRI Following Stereotactic Radiosurgery (SRS) for Brain Metastases Status ACTIVE_NOT_RECRUITING Phase NA
NCT04233021 Study of Osimertinib in Patients with a Lung Cancer with Brain or Leptomeningeal Metastases with EGFR Mutation Status COMPLETED Phase PHASE2
NCT04213170 Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung Cancer Status UNKNOWN Phase PHASE2
NCT04211090 Camrelizumab With AC in Patients With Brain Metastases of Driven Gene-negative,NSCLC Status UNKNOWN Phase PHASE2
NCT04193007 The Role of Brain Radiotherapy in Patients With Asymptomatic Brain Metastasis in the Era of Targeted Therapy for NSCLC Status UNKNOWN Phase PHASE2
NCT04192981 GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Leptomeningeal Metastases Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04178330 Tomotherapy as Primary Radiotherapy for Multipule Brain Metastases Status COMPLETED Phase NA
NCT04158947 A Study of HER2+ Breast Cancer Patients With Active Brain Metastases Treated With Afatinib & T-DM1 vs. T-DM1 Alone Status UNKNOWN Phase PHASE2
NCT04094077 Evaluating AGuIX® Nanoparticles in Combination With Stereotactic Radiation for Brain Metastases Status TERMINATED Phase PHASE2
NCT04084431 Supportive Care With or Without Repeated Whole Brain Radiotherapy in Patients With Recurrent Brain Metastases Status WITHDRAWN Phase NA
NCT04074096 Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain Metastasis Status ACTIVE_NOT_RECRUITING Phase PHASE2